SMLR - Semler Scientific, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
43.25
+0.85 (+2.00%)
As of 12:49PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close42.40
Open42.50
Bid0.00 x 0
Ask0.00 x 0
Day's Range42.50 - 43.50
52 Week Range7.72 - 43.50
Volume14,571
Avg. Volume16,523
Market Cap273.555M
Beta (3Y Monthly)1.13
PE Ratio (TTM)65.53
EPS (TTM)0.66
Earnings DateApr 29, 2019 - May 3, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.00
Trade prices are not sourced from all markets
  • Zacks Small Cap Research17 days ago

    SMLR: Revenue, Earnings & Cash Flow Continue to Climb. Cash Flow Forecast Implies $45/Share Fair Value

    Q4 2018 Results: Revenue, Earnings & Cash Flow Continue to Climb. Semler (SMLR) reported financial results for the fourth quarter ending December 31, 2018. While revenue slightly missed our estimate, it nonetheless came in strong – up 42% yoy, 7% better than Q3 and a new record high.

  • PR Newswire19 days ago

    Semler Reports Fourth Quarter and Year End 2018 Financial Results

    2018 HIGHLIGHTS compared to 2017: - Annual revenue increased by 73% - Net income after tax grew to $0.82 per basic share and $0.66 per diluted share, compared to a net loss of $0.28 per basic and diluted ...

  • PR Newswirelast month

    Semler to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call on February 27, 2019

    SAN JOSE, Calif., Feb. 14, 2019 /PRNewswire/ -- Semler Scientific, Inc. (SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for fourth quarter and full year ended December 31, 2018 before the open of U.S. financial markets on Wednesday, February 27, 2019. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day. Please specify to the operator that you would like to join the "Semler Fourth Quarter and Year End 2018 Financial Results Call, conference ID#: 3068129." The conference call will be archived on Semler's website at www.semlerscientific.com.

  • Zacks Small Cap Research5 months ago

    SMLR: Revenue up 55%, cash flow continues to churn, balance sheet cleaned, moving PT to $35/share

    Net income and EPS through the first nine months of the year was $3.6M and $0.48, compared to a $1.8M net loss and ($0.33) EPS in the comparable prior year period. Each of the last several consecutive quarters’ financial results has incrementally bolstered the likely long-term viability of Semler’s business model and sustainability of growth of revenue/earnings/cash flow-generation.

  • GuruFocus.com5 months ago

    US Market Indexes Close Lower on Friday

    Nasdaq Composite closes at 7,167.21 for a loss of -2.06%

  • PR Newswire5 months ago

    Semler to Report Third Quarter and First Nine Months of 2018 Financial Results and Host Conference Call on October 26, 2018

    SAN JOSE, Calif. , Oct. 16, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness ...

  • Zacks Small Cap Research7 months ago

    SMLR: Phenomenal Q2, Further Validates Business Model. $25 PT Could Still Be Conservative

    Q2 2018 provided the most validation as it relates to that theme with revenue, net income, EPS and cash flow all crushing prior bests – most impressive was EPS of $0.19 (and that’s a clean $0.19). The consistency and regularity of revenue growth and flatness of expenses lend credence to the validity of the company’s business model and strategy. Much of that hinges on the supposition that insurers have an economic interest in paying for their capitation-based insured to be tested for PAD.

  • ACCESSWIRE8 months ago

    Semler Scientific, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 31, 2018 / Semler Scientific, Inc. (OTCQB: SMLR ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 31, 2018 at 11:00 AM Eastern Time. ...

  • PR Newswire8 months ago

    Semler Reports Second Quarter and First Half 2018 Financial Results

    Continued Growth in Revenues and Earnings SAN JOSE, Calif. , July 31, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve ...

  • PR Newswire8 months ago

    Semler to Report Second Quarter and First Half 2018 Financial Results and Host Conference Call on July 31, 2018

    SAN JOSE, Calif., July 23, 2018 /PRNewswire/ -- Semler Scientific, Inc. (SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report second quarter and first half 2018 financial results before the open of U.S. financial markets on Tuesday, July 31, 2018. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day. The conference call may be accessed by dialing (877) 359-9508 for domestic callers and (224) 357-2393 for international callers.

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of SMLR earnings conference call or presentation 1-May-18 3:00pm GMT

    Q1 2018 Semler Scientific Inc Earnings Call

  • Zacks Small Cap Research10 months ago

    SMLR: Q1 2018 Results: Blowout Quarter: Record Revenue (again), Op Income, Net Income. Upwardly Revising Estimates (again)

    By Brian Marckx, CFA OTC:SMLR Semler Scientific (OTC:SMLR) reported financial results for their first quarter ending March 31, 2018. Revenue, profitability and cash flow continue to show regular and significant ...

  • PR Newswire11 months ago

    Semler to Report First Quarter 2018 Financial Results and Host Conference Call on May 1, 2018

    SAN JOSE, Calif., April 19, 2018 /PRNewswire/ -- Semler Scientific, Inc. (SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report first quarter 2018 financial results before the open of U.S. financial markets on Tuesday, May 1, 2018. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day. The conference call may be accessed by dialing 877-359-9508 for domestic callers and 224-357-2393 for international callers.